|
|||||||
|
|
|||||||
| Case Report | |||||||
|
|
|||||||
| Volume 5, Number 2, April 2012, pages 67-70 | |||||||
|
|
|||||||
|
A Flare of Ulcerative Colitis Accompanied With Cerebral Sinus Venous Thrombosis And Bilateral Thalamic Infarctus: A Case Report
aYuzuncu Yil University, Department of Gastroenterology, Van, Turkey bYuzuncu Yil University, Department of Internal Medicine, Van, Turkey cIpekyolu Public Hospital, Department of Internal Medicine, Van, Turkey
dCorresponding
author: Huseyin Begenik, Yuzuncu Yil Universitesi Tip Fakultesi Egitim
ve Arastırma Hastanesi, Ic Hastaliklari Klinigi Van, Turkey. Email:
hbegenik@hotmail.com
Manuscript accepted for publication February 14, 2012 Short title: Flare of Ulcerative Colitis Accompanied doi:10.4021/gr403w
Abstract
Ulcerative colitis (UC)
is a chronic inflammatory and recurrent disorder that is characterized
by bowel inflammation. Some patients with Inflammatory Bowel Disease
(IBD) have acute, severe, and sometimes devastating intracranial
complications that require immediate medical intervention. Cerebral
sinus vein thrombosis is a rare but serious extraintestinal complication
associated with ulcerative colitis. Herein we report a 30-year-old man
with UC who presented with a flare of gastrointestinal symptoms with
mental obtundation and apathy. Total colonoscopy revealed active colitis
and cranial MRI showed extensive cerebral sinus venous thrombosis with
thalamic infarcts. Because the patient was clinically unstable
metilprednisolon with low molecular weight heparin were administered.
Two days after treatment the patient was died despite all medical
efforts.
Keywords:
Ulcerative colitis; Sinus vein thrombosis;
Thalamic infarcts Introductıon Ulcerative colitis (UC) is a chronic inflammatory disease of the large bowel and is characterized by rectal bleeding and diarrhea [1]. UC is a result of inappropriate and ongoing activation of the mucosal immune system of large bowel. This anormal activaton is most likely due to defects in both the barrier function of the intestinal epithelium and the mucosal immune system [2]. The diagnosis of UC is generally established by endoscopic, histologic and radiologic examinations as well as laboratory tests. The medical treatment of ulcerative colitis has depend mainly on 5-aminosalicylates, corticosteroids, immunosuppressant, including thiopurine antimetabolites, and cyclosporine. These therapies are based on extent and severity of the disease [3-5]. Patients with UC commonly present with a wide range extraintestinal manifestations. Hypercoagulability-related disorders are well-recognized complications of UC. Hypercoagulability may manifest as thromboembolic events in many organ systems as well as intracranial vascular system [6].
Aseptic cerebral venous
and sinus thrombosis (CVST) is characterised by headache, seizures,
focal neurological deficits, altered consciousness, and papilledema [7].
Case Report A 30-year-old man presented to our hospital with a 2-year history of UC. He also had fever, abdominal pain with increasingly frequent bloody diarrhea, and a 2-week history of cefalgia and drowsiness that was relieved when he was taken NSAI drugs. There was no family history of inflammatory bowel diseases. The patient’s medications included meselamine, at a dose of 1000 mg thrice daily and pantoprazol 40 mg daily. He took a nonsteroidal anti-inflammatory drug on an as-needed basis. On physical examination, his blood pressure was 110/75 mmHg and heart rate was 90 beats per minute and regular. His temperature was 39.0 ºC. There was diffuse nonspesific tenderness to palpation of abdomen. His neurologic examination revealed stupor, papilledema and right hemiplegia. Glasgow coma score was calculated as 5 point. The hemoglobin level was 9.3 g per deciliter, with a mean corpuscular volume of 76 μm3. The white-cell count was 10400 per cubic millimeter, and the platelet count was 391,000 per cubic millimeter. The erythrocyte sedimentation rate was 50 mm per hour, and the C-reactive protein level was 132 mg per deciliter. Other laboratory values were as follows: sodium, 135 mmol per liter; potassium, 3.8 mmol per liter; blood urea nitrogen, 14 mg per deciliter; creatinine, 0.7 mg per deciliter; lipase, 20 U per liter. The serum albumin level was 3.0 g per deciliter. The liver-related transaminases and cholestatic enzymes, the anticardiolipin immunoglobulin levels were also in normal ranges. The patient had a negative lupus anticoagulant and had also normal homocystein levels. Protein S activity was 35% (normal: 60 - 150) and the antithrombin level was 45 % (normal, 85 - 125%). Stool cultures and examination of stool samples for signs of ova and parasites were also negative. A serologic test to rule out Entomoeba hystolitica was negative.
During the admittion,
the patient underwent a limited colonoscopic examination as far as the
splenic flexure and linear ulcerations were detected. The mucosal
appearance was given a score of 3 which was consistent with a heavy
flare of UC and five mucosal-biopsy specimens were obtained (Fig.
1). Pathologic examination of these samples
was revealed UC. Chest and abdomen radiography revealed no
abnormalities. Ultrasonography of the abdomen showed a thickened colonic
segment, without free air.
Discussion A patient presented in this case report manifested clinical and radiologic evidence of an acute sinus vein thrombosis in association with an acute flare of ulcerative colitis. Although UC is an intestinal disease, the outcome may depend upon a variety of extraintestinal complications, which develops overtime or suddenly [2]. As an extraintestinal complication, sinus vein thrombosis is very rare and may be fatal. The complex interactions between thrombosis and UC have not been well- characterised. But, accumulating evidence suggests that UC is a key factor in the development of thrombotic complications [8, 9]. Thrombocytosis, hyperfibrinogenemia, elevated levels of factor V, and factor VIII; antithrombin III deficiency; protein S deficiency are related to active bowel inflammation and may play a major role for thrombosis [10-14]. Recent studies showed that patients with ulcerative colitis have more frequently lower circulating protein S levels than normal controls [15, 16]. Additionaly, a reduced level of antithrombin III leading to an increased risk for thrombosis during the course of ulcerative colitis [17, 18]. However, the mechanism involved in the appearance of these coagulation abnormalities in patients with ulcerative colitis remains to be clarified [19]. Furthermore, no predisposing factor can be found in more than 50% patients with UC [9]. In our patient, the protein S activity and the level of anti-thrombin III were low and those detected abnormalities may contribute to development of sinus vein thrombosis as well as thalamic infarcts. Defective activity of methylenetetrahydrofolate reductase also has been reported among patients with UC. It is linked to folate and vitamin B12 deficiency and causes hyperhomocysteinemia-related thrombosis [20]. In presented case, the level of homocystein was in normal ranges. Prevalence of sinus vein thrombosis is reportedly found less than 1% among patients with inflammatory bowel disease [21, 22]. Most affected areas are reported as superior sagittal sinus and lateral sinuses [23]. However, association of thalamic infarcts with sinus vein thrombosis has rarely reported in English literature [24]. Despite the ideal treatment of ulcerative colitis- related sinus vein thrombosis is not well-established, Low Molecular Weight Heparin (LMWH) is most preferred agent to treat of this devastating complication [14] but despite all efforts, clinical endpoint of the discussed case was worst due to progressive intracranial complications.
Taken together, to determine and to
prevent intracranial complications, clinicians should remain vigilant in
patients with UC those have neurologic symptoms. Furthermore, neurologic
symptoms should routinely be checked by clinicians during acute attacks
of ulcerative colitis. |
|||||||
|
|
|||||||
| References | |||||||
|
|
|||||||
| 1. |
Hanauer SB.
Medical therapy of ulcerative colitis. Lancet. 1993;342(8868):412-417.
[Medline] [CrossRef] |
| 2. |
Podolsky DK.
Inflammatory bowel disease. N Engl J Med. 2002;347(6):417-429. [Medline] [CrossRef] |
| 3. |
Hanauer SB.
Medical therapy for ulcerative colitis 2004. Gastroenterology.
2004;126(6):1582-1592. [Medline] [CrossRef] |
| 4. |
Lichtiger S,
Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, et
al. Cyclosporine in severe ulcerative colitis refractory to steroid
therapy. N Engl J Med. 1994;330(26):1841-1845. [Medline] [CrossRef] |
| 5. |
Faubion WA,
Jr., Loftus EV, Jr., Harmsen WS, Zinsmeister AR, Sandborn WJ. The
natural history of corticosteroid therapy for inflammatory bowel
disease: a population-based study. Gastroenterology.
2001;121(2):255-260. [Medline] [CrossRef] |
| 6. |
Miehsler W,
Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, Grisar
J, et al. Is inflammatory bowel disease an independent and disease
specific risk factor for thromboembolism? Gut. 2004;53(4):542-548. [Medline] [CrossRef] |
| 7. |
Ameri A,
Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10(1):87-111.
[Medline] |
| 8. |
Quera R,
Shanahan F. Thromboembolism--an important manifestation of inflammatory
bowel disease. Am J Gastroenterol. 2004;99(10):1971-1973. [Medline] [CrossRef] |
| 9. |
Solem CA,
Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in
inflammatory bowel disease. Am J Gastroenterol. 2004;99(1):97-101. [Medline] [CrossRef] |
| 10. |
Harrison MJ,
Truelove SC. Cerebral venous thrombosis as a complication of ulcerative
colitis. Am J Dig Dis. 1967;12(10):1025-1028. [Medline] [CrossRef] |
| 11. |
Das R,
Vasishta RK, Banerjee AK. Aseptic cerebral venous thrombosis associated
with idiopathic ulcerative colitis: a report of two cases. Clin Neurol
Neurosurg. 1996;98(2):179-182. [Medline] [CrossRef] |
| 12. |
Hollander D.
Inflammatory bowel diseases and brain-gut axis. J Physiol Pharmacol.
2003;54 Suppl 4:183-190. [Medline] |
| 13. |
Franco-Ruiz
CA. [Thrombosis of the cerebral venous sinuses associated to ulcerative
colitis. A case report]. Rev Neurol. 2004;39(4):396-397. [Medline] |
| 14. |
Umit H, Asil
T, Celik Y, Tezel A, Dokmeci G, Tuncbilek N, Utku U, et al. Cerebral
sinus thrombosis in patients with inflammatory bowel disease: a case
report. World J Gastroenterol. 2005;11(34):5404-5407. [Medline] |
| 15. |
Koutroubakis
IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki
M, Kouroumalis EA, et al. Resistance to activated protein C and low
levels of free protein S in Greek patients with inflammatory bowel
disease. Am J Gastroenterol. 2000;95(1):190-194. [Medline] [CrossRef] |
| 16. |
Zezos P,
Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N.
Thrombophilic abnormalities of natural anticoagulants in patients with
ulcerative colitis. Hepatogastroenterology. 2007;54(77):1417-1421. [Medline] |
| 17. |
Knot EA, ten
Cate JW, Bruin T, Iburg AH, Tytgat GN. Antithrombin III metabolism in
two colitis patients with acquired antithrombin III deficiency.
Gastroenterology. 1985;89(2):421-425. [Medline] |
| 18. |
Cakal B,
Gokmen A, Yalinkilic M, Cakal E, Ayaz S, Nadir I, Ozin Y, et al. Natural
anticoagulant protein levels in Turkish patients with inflammatory bowel
disease. Blood Coagul Fibrinolysis. 2010;21(2):118-121. [Medline] [CrossRef] |
| 19. |
Kawanishi M,
Yoshida Y, Sakaguchi I, Nagano F, Kato K, Miyake H. Cerebral venous
sinus thrombosis in a patient with ulcerative colitis. J Stroke
Cerebrovasc Dis. 2003;12(6):271-275. [Medline] [CrossRef] |
| 20. |
Mahmud N,
Molloy A, McPartlin J, Corbally R, Whitehead AS, Scott JM, Weir DG.
Increased prevalence of methylenetetrahydrofolate reductase C677T
variant in patients with inflammatory bowel disease, and its clinical
implications. Gut. 1999;45(3):389-394. [Medline] [CrossRef] |
| 21. |
Talbot RW,
Heppell J, Dozois RR, Beart RW, Jr. Vascular complications of
inflammatory bowel disease. Mayo Clin Proc. 1986;61(2):140-145. [Medline] |
| 22. |
Lossos A,
River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel
disease. Neurology. 1995;45(3 Pt 1):416-421. [Medline] |
| 23. |
Srivastava
AK, Khanna N, Sardana V, Gaekwad S, Prasad K, Behari M. Cerebral venous
thrombosis in ulcerative colitis. Neurol India. 2002;50(2):215-217. [Medline] |
| 24. |
Silburn PA,
Sandstrom PA, Staples C, Mowat P, Boyle RS. Deep cerebral venous
thrombosis presenting as an encephalitic illness. Postgrad Med J.
1996;72(848):355-357. [Medline] [CrossRef] |
This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Digital Object Identifier (DOI):10.4021/gr403w
About
DOI and
CrossRef
Gastroenterology Research is a member of CrossRef.
![]()




